Cizzle Biotechnology Holdings PLC Notice of Annual General Meeting
03 Juin 2024 - 8:00AM
RNS Regulatory News
RNS Number : 7441Q
Cizzle Biotechnology Holdings PLC
03 June 2024
Cizzle Biotechnology Holdings
plc
("Cizzle
Biotechnology", or the "Company")
Notice of Annual General
Meeting
Cizzle Biotechnology, the UK based
diagnostics developer, announces that the notice of Annual
General Meeting ("AGM"), has been sent to shareholders and is
available for viewing on the Company's
website at https://cizzlebiotechnology.com.
The AGM will
be held at 11.00 a.m. on 24 June 2024 at the offices of Shakespeare
Martineau LLP, 6th Floor, 60 Gracechurch Street, London,
EC3V 0HR.
Enquiries:
|
Cizzle Biotechnology Holdings plc
|
Via IFC Advisory
|
|
Allan Syms (Executive
Chairman)
|
|
|
Allenby Capital Limited
|
+44(0) 20 3328 5656
|
|
John Depasquale
|
|
|
George Payne
|
|
|
|
| |
|
Novum Securities Limited
|
+44(0) 20 7399 9400
|
|
Colin Rowbury
Jon Bellis
|
|
|
IFC
Advisory Limited
|
+44(0) 20 3934 6630
|
|
Tim Metcalfe
|
|
|
Florence Chandler
|
|
About Cizzle Biotechnology
Cizzle Biotechnology is developing a
blood test to facilitate the early detection of lung cancer based
on the ability to detect a stable plasma biomarker, a variant of
CIZ1 known as CIZ1B. CIZ1 is a naturally occurring cell
nuclear protein involved in DNA replication, and the targeted CIZ1B
variant has been shown to be highly correlated with early-stage
lung cancer. The Company's proprietary technology results
from the work of Professor Coverley and colleagues at the
University of York.
For more information please
see https://cizzlebiotechnology.com
You can also follow the Company
through its twitter account @CizzlePlc and on LinkedIn.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact
rns@lseg.com or visit
www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our
Privacy
Policy.
END
NOAQKDBBNBKDPAK
Cizzle Biotechnology (LSE:CIZ)
Graphique Historique de l'Action
De Nov 2024 à Déc 2024
Cizzle Biotechnology (LSE:CIZ)
Graphique Historique de l'Action
De Déc 2023 à Déc 2024
